Oppenheimer Starts Verastem (VSTM) at Outperform, Positive on Targeting Cancer Stem Cells Therapy

Go back to Oppenheimer Starts Verastem (VSTM) at Outperform, Positive on Targeting Cancer Stem Cells Therapy
VERASTEM SHS (NASDAQ: VSTM) Delayed: 6.58 --0 (-0%)
Previous Close $6.58    52 Week High $2.43 
Open $6.58    52 Week Low $1.05 
Day High $6.58    P/E N/A 
Day Low $6.58    EPS $-1.79 
Volume 330